The DOI matches its Crossref record; 195 of the 195 references it cites were found in a registry or an index.
Tryptophan-kynurenine pathway is dysregulated in inflammation and immune activation
Open accessAbstract
The kynurenine (Kyn) pathway is the major route for tryptophan (Trp) metabolism, and it contributes to several fundamental biological processes. Trp is constitutively oxidized by tryptophan 2, 3-dioxygenase in liver cells. In other cell types, it is catalyzed by an alternative inducible indoleamine-pyrrole 2, 3-dioxygenase (IDO) under certain pathophysiological conditions, which consequently increases the formation of Kyn metabolites. IDO is up-regulated in response to inflammatory conditions as a novel marker of immune activation in early atherosclerosis. Besides, IDO and the IDO-related pathway are important mediators of the immunoinflammatory responses in advanced atherosclerosis. In particular, Kyn, 3-hydroxykynurenine, and quinolinic acid are positively associated with inflammation, oxidative stress (SOX), endothelial dysfunction, and carotid artery intima-media thickness values in end-stage renal disease patients. Moreover, IDO is a potential novel contributor to vessel relaxation and metabolism in systemic infections, which is also activated in acute severe heart attacks. The Kyn pathway plays a key role in the increased prevalence of cardiovascular disease by regulating inflammation, SOX, and immune activation.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
RETRACTED: Curcumin restores Nrf2 levels and prevents quinolinic acid-induced neurotoxicity
Carmona-Ramírez, I., Santamaría, A., Tobón-Velasco, J. C., Orozco‐Ibarra, M., González-Herrera, I. G., Pedraza‐Chaverrí, J., & Maldonado, P. D. (2012) · The Journal of Nutritional Biochemistry · doi:10.1016/j.jnutbio.2011.12.010 · Cited by 65
RetractedIdo expression by dendritic cells: tolerance and tryptophan catabolism
Mellor, A. L., & Munn, D. H. (2004) · Nature Reviews Immunology · doi:10.1038/nri1457 · Cited by 2,341
Inhibition of T Cell Proliferation by Macrophage Tryptophan Catabolism
Munn, D. H., Shafizadeh, E., Attwood, J. T., Bondarev, I., Pashine, A., & Mellor, A. L. (1999) · The Journal of Experimental Medicine · doi:10.1084/jem.189.9.1363 · Cited by 1,623
Kynurenines in the mammalian brain: when physiology meets pathology
Schwarcz, R., Bruno, J. P., Muchowski, P. J., & Wu, H.-Q. (2012) · Nature Reviews Neuroscience · doi:10.1038/nrn3257 · Cited by 1,530
CTLA-4–Ig regulates tryptophan catabolism in vivo
Grohmann, U., Orabona, C., Fallarino, F., Vacca, C., Calcinaro, F., Falorni, A., Candeloro, P., Belladonna, M. L., Bianchi, R., Fioretti, M. C., et al. (2002) · Nature Immunology · doi:10.1038/ni846 · Cited by 1,161
Indoleamine 2,3-dioxygenase and tumor-induced tolerance
Munn, D. H., & Mellor, A. L. (2007) · Journal of Clinical Investigation · doi:10.1172/jci31178 · Cited by 1,078
Kremer, J. M., Westhovens, R., Leon, M., Di Giorgio, E., Alten, R., Steinfeld, S., Russell, A., Dougados, M., Emery, P., Nuamah, I. F., et al. (2003) · New England Journal of Medicine · doi:10.1056/nejmoa035075 · Cited by 1,058
T cell apoptosis by tryptophan catabolism
Fallarino, F., Grohmann, U., Vacca, C., Bianchi, R., Orabona, C., Spreca, A., Fioretti, M. C., & Puccetti, P. (2002) · Cell Death & Differentiation · doi:10.1038/sj.cdd.4401073 · Cited by 1,022
Neuropharmacology of quinolinic and kynurenic acids.
Stone, T. W. (1993) · Pharmacological Reviews · doi:10.1016/s0031-6997(25)00441-7 · Cited by 948
Hilmas, C., Pereira, E. F. R., Alkondon, M., Rassoulpour, A., Schwarcz, R., & Albuquerque, E. X. (2001) · The Journal of Neuroscience · doi:10.1523/jneurosci.21-19-07463.2001 · Cited by 859
Endogenous kynurenines as targets for drug discovery and development
Stone, T. W., & Darlington, L. G. (2002) · Nature Reviews Drug Discovery · doi:10.1038/nrd870 · Cited by 768
Blood–Brain Barrier Transport of Kynurenines: Implications for Brain Synthesis and Metabolism
Fukui, S., Schwarcz, R., Rapoport, S. I., Takada, Y., & Smith, Q. R. (1991) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.1991.tb03460.x · Cited by 761
Agudelo, L. Z., Femenía, T., Orhan, F., Porsmyr-Palmertz, M., Goiny, M., Martinez-Redondo, V., Correia, J. C., Izadi, M., Bhat, M., Schuppe-Koistinen, I., et al. (2014) · Cell · doi:10.1016/j.cell.2014.07.051 · Cited by 739
Kynurenic Acid as a Ligand for Orphan G Protein-coupled Receptor GPR35
Wang, J., Simonavicius, N., Wu, X., Swaminath, G., Reagan, J., Tian, H., & Ling, L. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m603503200 · Cited by 687
Kynurenines in the CNS: recent advances and new questions
Vécsei, L., Szalárdy, L., Fülöp, F., & Toldi, J. (2013) · Nature Reviews Drug Discovery · doi:10.1038/nrd3793 · Cited by 641
Holmgaard, R. B., Zamarin, D., Munn, D. H., Wolchok, J. D., & Allison, J. P. (2013) · Journal of Experimental Medicine · doi:10.1084/jem.20130066 · Cited by 634
Melillo, G., Musso, T., Sica, A., Taylor, L. S., Cox, G. W., & Varesio, L. (1995) · The Journal of experimental medicine · doi:10.1084/jem.182.6.1683 · Cited by 626
Quinolinic acid, the inescapable neurotoxin
Guillemin, G. J. (2012) · The FEBS Journal · doi:10.1111/j.1742-4658.2012.08485.x · Cited by 595
Reversal of tumoral immune resistance by inhibition of tryptophan 2,3-dioxygenase
Pilotte, L., Larrieu, P., Stroobant, V., Colau, D., Dolušić, E., Frédérick, R., De Plaen, E., Uyttenhove, C., Wouters, J., Masereel, B., et al. (2012) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1113873109 · Cited by 572
Manipulation of Brain Kynurenines: Glial Targets, Neuronal Effects, and Clinical Opportunities
Schwarcz, R., & Pellicciari, R. (2002) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.102.034439 · Cited by 556
Kynurenine pathway metabolism in human astrocytes: a paradox for neuronal protection
Guillemin, G. J., Kerr, S. J., Smythe, G. A., Smith, D. G., Kapoor, V., Armati, P. J., Croitoru, J., & Brew, B. J. (2001) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2001.00498.x · Cited by 538
Kynurenine 3-Monooxygenase Inhibition in Blood Ameliorates Neurodegeneration
Zwilling, D., Huang, S.-Y., Sathyasaikumar, K. V., Notarangelo, F. M., Guidetti, P., Wu, H.-Q., Lee, J., Truong, J., Andrews-Zwilling, Y., Hsieh, E. W., et al. (2011) · Cell · doi:10.1016/j.cell.2011.05.020 · Cited by 515
O'Connor, J. C., André, C., Wang, Y., Lawson, M. A., Szegedi, S. S., Lestage, J., Castanon, N., Kelley, K. W., & Dantzer, R. (2009) · The Journal of Neuroscience · doi:10.1523/jneurosci.5032-08.2009 · Cited by 502
Okuda, S., Nishiyama, N., Saito, H., & Katsuki, H. (1998) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1998.70010299.x · Cited by 462
Kynurenine is an endothelium-derived relaxing factor produced during inflammation
Wang, Y., Liu, H., McKenzie, G., Witting, P. K., Stasch, J.-P., Hahn, M., Changsirivathanathamrong, D., Wu, B. J., Ball, H. J., Thomas, S. R., et al. (2010) · Nature Medicine · doi:10.1038/nm.2092 · Cited by 446
Quinolinic acid: an endogenous neurotoxin with multiple targets
Lugo-Huitrón, R., Ugalde Muñiz, P., Pineda, B., Pedraza-Chaverrí, J., Ríos, C., & Pérez-de la Cruz, V. (2013) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2013/104024 · Cited by 394
Cytokine–serotonin interaction through IDO: a neurodegeneration hypothesis of depression
Myint, A. M., & Kim, Y. K. (2003) · Medical Hypotheses · doi:10.1016/s0306-9877(03)00207-x · Cited by 374
Lugo-Huitrón, R., Blanco-Ayala, T., Ugalde-Muñiz, P., Carrillo-Mora, P., Pedraza-Chaverrí, J., Silva-Adaya, D., Maldonado, P. D., Torres, I., Pinzón, E., Ortiz-Islas, E., et al. (2011) · Neurotoxicology and Teratology · doi:10.1016/j.ntt.2011.07.002 · Cited by 346
Biochemical and medical aspects of the indoleamine 2,3-dioxygenase-initiated l-tryptophan metabolism
Takikawa, O. (2005) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2005.09.032 · Cited by 337
Christen, S., Peterhans, E., & Stocker, R. (1990) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.87.7.2506 · Cited by 334
Giorgini, F., Guidetti, P., Nguyen, Q., Bennett, S. C., & Muchowski, P. J. (2005) · Nature Genetics · doi:10.1038/ng1542 · Cited by 328
Brain indoleamine 2,3-dioxygenase contributes to the comorbidity of pain and depression
Kim, H., Chen, L., Lim, G., Sung, B., Wang, S., McCabe, M. F., Rusanescu, G., Yang, L., Tian, Y., & Mao, J. (2012) · Journal of Clinical Investigation · doi:10.1172/jci61884 · Cited by 324
Birch, P. J., Grossman, C. J., & Hayes, A. G. (1988) · European Journal of Pharmacology · doi:10.1016/0014-2999(88)90367-6 · Cited by 318
Okuda, S., Nishiyama, N., Saito, H., & Katsuki, H. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.22.12553 · Cited by 301
Inflammation, Glutamate, and Glia in Depression:A Literature Review
McNally, L., Bhagwagar, Z., & Hannestad, J. (2008) · CNS Spectrums · doi:10.1017/s1092852900016734 · Cited by 289
Kanai, M., Funakoshi, H., Takahashi, H., Hayakawa, T., Mizuno, S., Matsumoto, K., & Nakamura, T. (2009) · Molecular Brain · doi:10.1186/1756-6606-2-8 · Cited by 273
Molecules in focus: Indoleamine 2,3-dioxygenase
King, N. J. C., & Thomas, S. R. (2007) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2007.01.004 · Cited by 259
Schefold, J. C., Zeden, J.-P., Fotopoulou, C., von Haehling, S., Pschowski, R., Hasper, D., Volk, H.-D., Schuett, C., & Reinke, P. (2009) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/gfn739 · Cited by 251
Vincenti, M. P. (2003) · Matrix Metalloproteinase Protocols · doi:10.1385/1-59259-046-2:121 · Cited by 245
Folsom, A. R., Aleksic, N., Park, E., Salomaa, V., Juneja, H., & Wu, K. K. (2001) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.21.4.611 · Cited by 234
Characterization of rat brain kynurenine aminotransferases I and II
Guidetti, P., Okuno, E., & Schwarcz, R. (1997) · Journal of Neuroscience Research · doi:10.1002/(sici)1097-4547(19971101)50:3<457::aid-jnr12>3.0.co;2-3 · Cited by 233
Neopterin production, tryptophan degradation, and mental depression—What is the link?
Widner, B., Laich, A., Sperner-Unterweger, B., Ledochowski, M., & Fuchs, D. (2002) · Brain, Behavior, and Immunity · doi:10.1016/s0889-1591(02)00006-5 · Cited by 231
Network beyond IDO in psychiatric disorders: Revisiting neurodegeneration hypothesis
Myint, A.-M., & Kim, Y.-K. (2014) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2013.08.008 · Cited by 230
Mechanism for Quinolinic Acid Cytotoxicity in Human Astrocytes and Neurons
Braidy, N., Grant, R., Adams, S., Brew, B. J., & Guillemin, G. J. (2009) · Neurotoxicity Research · doi:10.1007/s12640-009-9051-z · Cited by 226
Behan, W. M. H., McDonald, M., Darlington, L. G., & Stone, T. W. (1999) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0702940 · Cited by 225
Identification and quantification of kynurenic acid in human brain tissue
Turski, W. A., Nakamura, M., Todd, W. P., Carpenter, B. K., Whetsell, W. O., & Schwarcz, R. (1988) · Brain Research · doi:10.1016/0006-8993(88)90815-3 · Cited by 219
Connor, T. J., Starr, N., O'Sullivan, J. B., & Harkin, A. (2008) · Neuroscience Letters · doi:10.1016/j.neulet.2008.06.007 · Cited by 215
Induction of indoleamine 2,3-dioxygenase in mouse lung during virus infection.
Yoshida, R., Urade, Y., Tokuda, M., & Hayaishi, O. (1979) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.76.8.4084 · Cited by 211
Goldstein, L. E., Leopold, M. C., Huang, X., Atwood, C. S., Saunders, A. J., Hartshorn, M., Lim, J. T., Faget, K. Y., Muffat, J. A., Scarpa, R. C., et al. (2000) · Biochemistry · doi:10.1021/bi992997s · Cited by 211
Thomas, S. R., & Stocker, R. (1999) · Redox Report · doi:10.1179/135100099101534927 · Cited by 208
Robinson, C. M., Hale, P. T., & Carlin, J. M. (2005) · Journal of Interferon & Cytokine Research · doi:10.1089/jir.2005.25.20 · Cited by 207
Alexander, A. M., Crawford, M., Bertera, S., Rudert, W. A., Takikawa, O., Robbins, P. D., & Trucco, M. (2002) · Diabetes · doi:10.2337/diabetes.51.2.356 · Cited by 204
Kynurenic acid: a metabolite with multiple actions and multiple targets in brain and periphery
Moroni, F., Cozzi, A., Sili, M., & Mannaioni, G. (2012) · Journal of Neural Transmission · doi:10.1007/s00702-011-0763-x · Cited by 203
Molecular insights into substrate recognition and catalysis by tryptophan 2,3-dioxygenase
Forouhar, F., Anderson, J. L. R., Mowat, C. G., Vorobiev, S. M., Hussain, A., Abashidze, M., Bruckmann, C., Thackray, S. J., Seetharaman, J., Tucker, T., et al. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0610007104 · Cited by 202
Immune activation and degradation of tryptophan in coronary heart disease
Wirleitner, B., Rudzite, V., Neurauter, G., Murr, C., Kalnins, U., Erglis, A., Trusinskis, K., & Fuchs, D. (2003) · European Journal of Clinical Investigation · doi:10.1046/j.1365-2362.2003.01186.x · Cited by 190
Alberati‐Giani, D., Ricciardi‐Castagnoli, P., Köhler, C., & Cesura, A. M. (1996) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1996.66030996.x · Cited by 187
Indoleamine 2,3-Dioxygenase: Is It an Immune Suppressor?
Soliman, H., Mediavilla-Varela, M., & Antonia, S. (2010) · The Cancer Journal · doi:10.1097/ppo.0b013e3181eb3343 · Cited by 184
Hayashi, T., Mo, J.-H., Gong, X., Rossetto, C., Jang, A., Beck, L., Elliott, G. I., Kufareva, I., Abagyan, R., Broide, D. H., et al. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0709261104 · Cited by 179
Increasing production of homocysteine and neopterin and degradation of tryptophan with older age
Frick, B., Schroecksnadel, K., Neurauter, G., Leblhuber, F., & Fuchs, D. (2004) · Clinical Biochemistry · doi:10.1016/j.clinbiochem.2004.02.007 · Cited by 178
Indoleamine 2,3-dioxygenase, tumor-induced tolerance and counter-regulation
Munn, D. H. (2006) · Current Opinion in Immunology · doi:10.1016/j.coi.2006.01.002 · Cited by 176
Quantitative aspects of tryptophan metabolism in humans and other species: a review
Leklem, J. E. (1971) · The American Journal of Clinical Nutrition · doi:10.1093/ajcn/24.6.659 · Cited by 172
Heyes, M. P., Saito, K., Major, E. O., Milstien, S., Markey, S. P., & Vickers, J. H. (1993) · Brain · doi:10.1093/brain/116.6.1425 · Cited by 170
Mitochondrial aspartate aminotransferase: a third kynurenate‐producing enzyme in the mammalian brain
Guidetti, P., Amori, L., Sapko, M. T., Okuno, E., & Schwarcz, R. (2007) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2007.04556.x · Cited by 166
On the Biological Importance of the 3-hydroxyanthranilic Acid: Anthranilic Acid Ratio
Darlington, L. G., Forrest, C. M., Mackay, G., Smith, R. A., Smith, A. J., Stoy, N. S., & Stone, T. W. (2010) · International Journal of Tryptophan Research · doi:10.4137/ijtr.s4282 · Cited by 159
On the relationship between the two branches of the kynurenine pathway in the rat brainin vivo
Amori, L., Guidetti, P., Pellicciari, R., Kajii, Y., & Schwarcz, R. M. (2009) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2009.05893.x · Cited by 154
Localization of indoleamine 2,3-dioxygenase in human female reproductive organs and the placenta.
Sedlmayr, P., Blaschitz, A., Wintersteiger, R., Semlitsch, M., Hammer, A., Mackenzie, C., Walcher, W., Reich, O., Takikawa, O., & Dohr, G. (2002) · Molecular human reproduction · doi:10.1093/molehr/8.4.385 · Cited by 154
Quinolinic acid induces oxidative stress in rat brain synaptosomes
Santamaría, A., Galván‐Arzate, S., Lisý, V., Ali, S. F., Duhart, H. M., Osorio‐Rico, L., Ríos, C., & Sut'astný, F. (2001) · Neuroreport · doi:10.1097/00001756-200103260-00049 · Cited by 152
Kynurenines with Neuroactive and Redox Properties: Relevance to Aging and Brain Diseases
Reyes-Ocampo, J. G., Lugo-Huitrón, R., González‐Esquivel, D. F., Ugalde‐Muñiz, P., Jiménez‐Anguiano, A., Pineda, B., Pedraza‐Chaverrí, J., Ríos, C., & de la Cruz, V. P. (2014) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2014/646909 · Cited by 151
Pertovaara, M., Raitala, A., Juonala, M., Lehtimäki, T. J., Huhtala, H., Oja, S. S., Jokinen, E. V., Viikari, J. S. A., Raitakari, O. T., & Hurme, M. (2007) · Clinical & Experimental Immunology · doi:10.1111/j.1365-2249.2007.03325.x · Cited by 150
Wu, H., Pereira, E., Bruno, J., Pellicciari, R., Albuquerque, E. X., & Schwarcz, R. (2009) · Journal of Molecular Neuroscience · doi:10.1007/s12031-009-9235-2 · Cited by 149
l-Kynurenine-induced apoptosis in human NK cells is mediated by reactive oxygen species
Song, H., Park, H., Kim, Y.-S., Kim, K. D., Lee, H.-K., Cho, D.-H., Yang, J.-W., & Hur, D. Y. (2011) · International Immunopharmacology · doi:10.1016/j.intimp.2011.02.005 · Cited by 148
Indoleamine 2,3-dioxygenase activity in nonagenarians is markedly increased and predicts mortality
Pertovaara, M., Raitala, A., Lehtimäki, T. J., Karhunen, P. J., Oja, S. S., Jylhä, M. K., Hervonen, A., & Hurme, M. (2006) · Mechanisms of Ageing and Development · doi:10.1016/j.mad.2006.01.020 · Cited by 139
Novel Protein Modification by Kynurenine in Human Lenses
Vazquez, S., Aquilina, J. A., Sheil, M. M., Truscott, R. J. W., & Jamie, J. F. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m107529200 · Cited by 138
The Role of Tryptophan Catabolism along the Kynurenine Pathway in Acute Ischemic Stroke
Brouns, R., Verkerk, R. M., Aerts, T., Surgeloose, D. D., Wauters, A., Scharpé, S., & Deyn, P. P. D. (2010) · Neurochemical Research · doi:10.1007/s11064-010-0187-2 · Cited by 137
Pawlak, K., Domaniewski, T., Myśliwiec, M., & Pawlak, D. (2008) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2008.08.014 · Cited by 136
Expression of indoleamine 2,3-dioxygenase and tryptophan 2,3-dioxygenase in early concepti
Suzuki, S., Toné, S., Takikawa, O., 俊一, 久., Kohno, I., & Minatogawa, Y. (2001) · Biochemical Journal · doi:10.1042/0264-6021:3550425 · Cited by 135
Daissormont, I., Christ, A., Temmerman, L., Sampedro, S., Seijkens, T. T. P., Manca, M., Rousch, M., Poggi, M., Boon, L., van der Loos, C. M., et al. (2011) · Circulation Research · doi:10.1161/circresaha.111.256529 · Cited by 135
Crucial Role of Interferon-γ and Stimulated Macrophages in Cardiovascular Disease
Schroecksnadel, K., Frick, B., Winkler, C., & Fuchs, D. (2006) · Current Vascular Pharmacology · doi:10.2174/157016106777698379 · Cited by 134
Wang, Q., Zhang, M., Ye, D., Wang, Q., Zhang, W., Song, P., & Zou, M. (2013) · Circulation Research · doi:10.1161/circresaha.114.302113 · Cited by 131
Self-citationDai, X., & Zhu, B. T. (2009) · Journal of Histochemistry & Cytochemistry · doi:10.1369/jhc.2009.953604 · Cited by 128
Swartz, K. J., Matson, W. R., MacGarvey, U. M., Ryan, E. A., & Beal, M. F. (1990) · Analytical Biochemistry · doi:10.1016/0003-2697(90)90309-w · Cited by 126
Synthesis and release of neurotoxic kynurenine metabolites by human monocyte-derived macrophages
Chiarugi, A., Calvani, M., Meli, E., Traggiai, E., & Moroni, F. (2001) · Journal of Neuroimmunology · doi:10.1016/s0165-5728(01)00418-0 · Cited by 125
Effect of quinolinic acid on endogenous antioxidants in rat corpus striatum
Rodríguez-Martínez, E., Camacho‐Morales, A., Maldonado, P. D., Pedraza‐Chaverrí, J., Santamarı́a, D., Galván‐Arzate, S., & Santamaría, A. (2000) · Brain Research · doi:10.1016/s0006-8993(99)02474-9 · Cited by 124
Jeong, Y.-I., Kim, S. W., Jung, I. D., Lee, J. S., Chang, J. H., Lee, C.-M., Chun, S. H., Yoon, M., Kim, G. T., Ryu, S. W., et al. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.m807328200 · Cited by 123
Astrocyte‐derived kynurenic acid modulates basal and evoked cortical acetylcholine release
Zmarowski, A., Wu, H., Brooks, J. M., Potter, M. C., Pellicciari, R., Schwarcz, R. M., & Bruno, J. P. (2009) · European Journal of Neuroscience · doi:10.1111/j.1460-9568.2008.06594.x · Cited by 122
Zhang, L., Овчинникова, О. А., Jönsson, A., Lundberg, A. M., Berg, M., Hansson, G. K., & Ketelhuth, D. F. J. (2012) · European Heart Journal · doi:10.1093/eurheartj/ehs175 · Cited by 121
Jung, I. D., Lee, M. G., Chang, J. H., Lee, J. S., Jeong, Y.-I., Lee, C. M., Park, W. S., Han, J., Seo, S., Lee, S. Y., et al. (2009) · The Journal of Immunology · doi:10.4049/jimmunol.0803104 · Cited by 120
Sulo, G., Vollset, S. E., Nygard, O. K., Midttun, Ø., Ueland, P. M., Eussen, S. J. P. M., Pedersen, E. R., & Tell, G. S. (2013) · International Journal of Cardiology · doi:10.1016/j.ijcard.2012.12.090 · Cited by 120
Tryptophan degradation increases with stage in patients with rheumatoid arthritis
Schroecksnadel, K., Winkler, C., Duftner, C., Wirleitner, B., Schirmer, M., & Fuchs, D. (2005) · Clinical Rheumatology · doi:10.1007/s10067-005-0056-6 · Cited by 120
Tryptophan as a Link between Psychopathology and Somatic States
Russo, S., Kema, I. P., Heiner‐Fokkema, R., Boon, J. C., Willemse, P. H. B., de Vries, E. G. E., den Boer, J. A., & Korf, J. (2003) · Psychosomatic Medicine · doi:10.1097/01.psy.0000078188.74020.cc · Cited by 119
CDllc + Cells Modulate Pulmonary Immune Responses by Production of Indoleamine 2,3-Dioxygenase
Swanson, K. A., Zheng, Y., Heidler, K. M., Mizobuchi, T., & Wilkes, D. S. (2003) · American Journal of Respiratory Cell and Molecular Biology · doi:10.1165/rcmb.2003-0268oc · Cited by 114
Uptake of Kynurenine into Rat Brain Slices
Speciale, C., & Schwarcz, R. M. (1990) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.1990.tb13296.x · Cited by 107
Pawlak, K., Myśliwiec, M., & Pawlak, D. (2010) · Advances in Medical Sciences · doi:10.2478/v10039-010-0015-6 · Cited by 107
In vivo hydroxyl radical formation after quinolinic acid infusion into rat corpus striatum
Santamaría, A., Jiménez-Capdeville, M. E., Camacho‐Morales, A., Rodríguez-Martínez, E., Flores, A., & Galván‐Arzate, S. (2001) · Neuroreport · doi:10.1097/00001756-200108280-00020 · Cited by 107
Niinisalo, P., Raitala, A., Pertovaara, M., Oja, S. S., Lehtimäki, T. J., Kähönen, M. A. P., Reunanen, A., Jula, A., Moilanen, L., Kesäniemi, Y. A., et al. (2008) · Scandinavian Journal of Clinical and Laboratory Investigation · doi:10.1080/00365510802245685 · Cited by 107
Leipnitz, G., Schumacher, C., Dalcin, K. B., Scussiato, K., Solano, A. F., Funchal, C., Dutra‐Filho, C. S., Wyse, Â. T. D. S., Wannmacher, C. M. D., Latini, A., et al. (2006) · Neurochemistry International · doi:10.1016/j.neuint.2006.04.017 · Cited by 106
GPR35 is a functional receptor in rat dorsal root ganglion neurons
Ohshiro, H., Tonai‐Kachi, H., & Ichikawa, K. (2007) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2007.10.197 · Cited by 106
Yü, P., Li, Z., Zhang, L., Tagle, D. A., & Cai, T. (2006) · Gene · doi:10.1016/j.gene.2005.09.034 · Cited by 102
Pláteník, J., Stopka, P., Vejražka, M., & Štípek, S. (2001) · Free Radical Research · doi:10.1080/10715760100300391 · Cited by 102
Alberati-Giani, D., Malherbe, P., Ricciardi‐Castagnoli, P., Köhler, C., Denis‐Donini, S., & Cesura, A. M. (1997) · The Journal of Immunology · doi:10.4049/jimmunol.159.1.419 · Cited by 101
Thomas, S. R., Witting, P. K., & Stocker, R. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.51.32714 · Cited by 101
Energetic Dysfunction in Quinolinic Acid‐Lesioned Rat Striatum
Bordelon, Y. M., Chesselet, M., Nelson, D., Welsh, F. A., & Erecińska, M. (1997) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1997.69041629.x · Cited by 100
Neuronal Apoptosis Induced by Pharmacological Concentrations of 3‐Hydroxykynurenine
Wei, H., Leeds, P. R., Chen, R., et al. (2000) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2000.0750081.x · Cited by 100
Tryptophan metabolism to kynurenine is a potential novel contributor to hypotension in human sepsis*
Changsirivathanathamrong, D., Wang, Y., Rajbhandari, D., Maghzal, G. J., Mak, W., Woolfe, C., Duflou, J. A., Gebski, V., dos Remedios, C. G., Celermajer, D. S., et al. (2011) · Critical Care Medicine · doi:10.1097/ccm.0b013e31822827f2 · Cited by 99
Giorgini, F., Möller, T., Kwan, W., Zwilling, D., Wacker, J. L., Hong, S. Y., Tsai, L. L., Cheah, C. S., Schwarcz, R. M., Guidetti, P., et al. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m708192200 · Cited by 98
Electrochemical and in vitro evaluation of the redox-properties of kynurenine species
Giles, G. I., Collins, C. A., Stone, T. W., & Jacob, C. (2003) · Biochemical and Biophysical Research Communications · doi:10.1016/s0006-291x(02)02917-0 · Cited by 97
The effect of quinolinate on rat brain lipid peroxidation is dependent on iron
Štípek, S., Šťastný, F., Plátenı́k, J., Crkovska, J., & Zima, T. (1997) · Neurochemistry International · doi:10.1016/s0197-0186(97)90002-4 · Cited by 97
Cuffy, M. C., Silverio, A. M., Qin, L., Wang, Y., Eid, R. E., Brandacher, G., Lakkis, F. G., Fuchs, D., Pober, J. S., & Tellides, G. (2007) · The Journal of Immunology · doi:10.4049/jimmunol.179.8.5246 · Cited by 96
Oh, G., Pae, H., Choi, B., Chae, S., Lee, H.-S., Ryu, D., & Chung, H. (2004) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2004.06.061 · Cited by 95
Kynurenine pathway in schizophrenia: pathophysiological and therapeutic aspects
Muller, N., Myint, A.-M., & J. Schwarz, M. (2011) · Current Pharmaceutical Design · doi:10.2174/138161211795049552 · Cited by 94 · cited 1×
“including central nervous system (CNS) disorders (4-8), peripheral disorders (9, 10), infections (11, 12), immunoregulation (10, 13, 14), and ultraviolet protection and cataract formation in the lens (15, 16).”
BackgroundMorita, T., Saito, K., Takemura, M., Maekawa, N., Fujigaki, S., Fujii, H., Wada, H., Takeuchi, S., Noma, A., & Seishima, M. (2001) · Annals of Clinical Biochemistry International Journal of Laboratory Medicine · doi:10.1258/0004563011900461 · Cited by 94
Brandacher, G., Winkler, C., Aigner, F., Schwelberger, H. G., Schroecksnadel, K., Margreiter, R., Fuchs, D., & Weiss, H. G. (2006) · Obesity Surgery · doi:10.1381/096089206776945066 · Cited by 92
Zaher, S. S., Germain, C., Fu, H., Larkin, F., & George, A. J. T. (2011) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.10-5793 · Cited by 89
The IDO Inhibitor Coptisine Ameliorates Cognitive Impairment in a Mouse Model of Alzheimer's Disease
Yu, D., Tao, B.-B., Yang, Y.-Y., Du, L., Yang, S.-S., He, X.-J., Zhu, Y., Yan, J., & Yang, Q. (2014) · Journal of Alzheimer's Disease · doi:10.3233/jad-140414 · Cited by 88
Pae, H., Oh, G., Lee, B.-S., Rim, J.-S., Kim, Y., & Chung, H. (2005) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2005.09.010 · Cited by 88
3-Hydroxykynurenine Toxicity on the Rat Striatum In Vivo
Nakagami, Y., Saitō, H., & Katsuki, H. (1996) · The Japanese Journal of Pharmacology · doi:10.1254/jjp.71.183 · Cited by 88
Pedersen, E. R., Svingen, G. F. T., Schartum-Hansen, H., Ueland, P. M., Ebbing, M., Nordrehaug, J. E., Igland, J., Seifert, R., Nilsen, R. M., & Nygard, O. K. (2013) · European Heart Journal · doi:10.1093/eurheartj/eht264 · Cited by 87
Braidy, N., Grant, R., Brew, B. J., Adams, S., Jayasena, T., & Guillemin, G. J. (2009) · International Journal of Tryptophan Research · doi:10.4137/ijtr.s2318 · Cited by 86
Jung, I. D., Lee, C.-M., Jeong, Y.-I., Lee, J. S., Park, W. S., Han, J., & Park, Y. (2007) · FEBS Letters · doi:10.1016/j.febslet.2007.02.073 · Cited by 85
Biochemical and Structural Properties of Mouse Kynurenine Aminotransferase III
Han, Q., Robinson, H. H., Cai, T., Tagle, D. A., & Li, J. (2008) · Molecular and Cellular Biology · doi:10.1128/mcb.01272-08 · Cited by 85
Pawlak, K., Brzόsko, S., Myśliwiec, M., & Pawlak, D. (2008) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2008.10.002 · Cited by 84
Nakajima, K., Yamashita, T., Kita, T., Takeda, M., Sasaki, N., Kasahara, K., Shinohara, M., Rikitake, Y., Ishida, T., Yokoyama, M., et al. (2011) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.111.229443 · Cited by 84
Hoshi, M., Saito, K., Hara, A., Taguchi, A., Ohtaki, H., Tanaka, R., Fujigaki, H., Osawa, Y., Takemura, M., Matsunami, H., et al. (2010) · The Journal of Immunology · doi:10.4049/jimmunol.0901150 · Cited by 83
Quinolinic acid: neurotoxicity
Guillemin, G. J. (2012) · FEBS Journal · doi:10.1111/j.1742-4658.2012.08493.x · Cited by 83
Lee, S., Lee, Y.-S., Choi, J.-H., Park, S.-G., Choi, I., Joo, Y., Lee, W.-S., Lee, J.-N., Choi, I., & Seo, S. (2010) · Immunology Letters · doi:10.1016/j.imlet.2010.05.008 · Cited by 82
Niinisalo, P., Oksala, N., Levula, M., Pelto‐Huikko, M., Järvinen, O., Salenius, J., Kytömäki, L., Soini, J. T., Kähönen, M. A. P., Laaksonen, R., et al. (2009) · Annals of Medicine · doi:10.3109/07853890903321559 · Cited by 82
Huttunen, R., Syrjänen, J., Aittoniemi, J., Oja, S. S., Raitala, A., Laine, J., Pertovaara, M., Vuento, R., Huhtala, H., & Hurme, M. (2010) · Shock · doi:10.1097/shk.0b013e3181ad3195 · Cited by 80
Midttun, Ø., Ulvik, A., Pedersen, E. R., Ebbing, M., Bleie, Ø., Schartum-Hansen, H., Nilsen, R. M., Nygard, O. K., & Ueland, P. M. (2011) · Journal of Nutrition · doi:10.3945/jn.110.133082 · Cited by 80
Targeting kynurenine 3-monooxygenase (KMO): implications for therapy in Huntington's disease.
Thevandavakkam, M., Schwarcz, R., Muchowski, P., & Giorgini, F. (2010) · CNS and Neurological Disorders - Drug Targets · doi:10.2174/187152710793237430 · Cited by 80
de la Cruz, V. P., González‐Cortés, C., Galván‐Arzate, S., Medina‐Campos, O. N., Pérez‐Severiano, F., Ali, S. F., Pedraza‐Chaverrí, J., & Santamaría, A. (2005) · Neuroscience · doi:10.1016/j.neuroscience.2005.06.027 · Cited by 77
Hansen, A. M., Ball, H. J., Mitchell, A. J., Miu, J., Takikawa, O., & Hunt, N. H. (2004) · International Journal for Parasitology · doi:10.1016/j.ijpara.2004.07.008 · Cited by 75
Pawlak, K., Naumnik, B., Brzόsko, S., Pawlak, D., & Myśliwiec, M. (2004) · American Journal of Nephrology · doi:10.1159/000076244 · Cited by 73
Xanthurenic acid distribution, transport, accumulation and release in the rat brain
Gobaille, S., Kemmel, V., Brumaru, D., Dugave, C., Aunis, D., & Maître, M. (2008) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2008.05219.x · Cited by 72
Functional characterization and mechanism of action of recombinant human kynurenine 3‐hydroxylase
Breton, J., Avanzi, N. R., Magagnin, S., Covini, N., Magistrelli, G., Cozzi, L., & Isacchi, A. (2000) · European Journal of Biochemistry · doi:10.1046/j.1432-1327.2000.01104.x · Cited by 70
Britan, A., Maffre, V., Toné, S., & Drevet, J. R. (2006) · Cell and Tissue Research · doi:10.1007/s00441-005-0151-7 · Cited by 69
谷崎, 優., Kobayashi, A., Toujima, S., Shiro, M., Mizoguchi, M., Mabuchi, Y., Yagi, S., Minami, S., Takikawa, O., & Ino, K. (2014) · Cancer Science · doi:10.1111/cas.12445 · Cited by 69
Zádori, D., Klivènyi, P., Plangár, I., Toldi, J., & Vécsei, L. (2010) · Journal of Cellular and Molecular Medicine · doi:10.1111/j.1582-4934.2010.01237.x · Cited by 69
Lima, V. L. A., Dias, F. D. A., Nunes, R. D., Pereira, L. D. O. R., Santos, T. S. R., Chiarini, L. B., Ramos, T. D., Mendes, B. J. D. S., Perales, J., Valente, R. H., et al. (2012) · PLoS ONE · doi:10.1371/journal.pone.0038349 · Cited by 67
Müller, A., Heseler, K., Schmidt, S. K., Spekker, K., MacKenzie, C. R., & Däubener, W. (2008) · Journal of Cellular and Molecular Medicine · doi:10.1111/j.1582-4934.2008.00542.x · Cited by 67
Sakash, J. B., Byrne, G. I., Lichtman, A. H., & Libby, P. (2002) · Infection and Immunity · doi:10.1128/iai.70.7.3959-3961.2002 · Cited by 66
3-Hydroxyglutaric acid moderately impairs energy metabolism in brain of young rats
Latini, A., Rodriguez, M., Rosa, R. B., Scussiato, K., Leipnitz, G., de Assis, D. R., Ferreira, G. C., Funchal, C., Jacques-Silva, M. C., Buzin, L., et al. (2005) · Neuroscience · doi:10.1016/j.neuroscience.2005.05.013 · Cited by 64
Quinolinic Acid and Active Oxygens
Goda, K., KISHIMOTO, R., Shimizu, S., Hamane, Y., & Ueda, M. (1996) · Advances in experimental medicine and biology · doi:10.1007/978-1-4613-0381-7_38 · Cited by 64
Goda, K., KISHIMOTO, R., Shimizu, S., Hamane, Y., & Ueda, M. (1996) · PubMed · Cited by 63
Isotope effects and alternative substrate reactivities for tryptophan 2,3-dioxygenase.
Leeds, J. M., Brown, P. J., McGeehan, G. M., Brown, F. K., & Wiseman, J. S. (1993) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)46773-1 · Cited by 59
Hardeland, R., Zsizsik, B. K., Pöeggeler, B., Fuhrberg, B., Holst, S., & Coto‐Montes, A. M. (1999) · Advances in experimental medicine and biology · doi:10.1007/978-1-4615-4709-9_49 · Cited by 59
Malina, H. Z., Richter, C., Mehl, M., et al. (2001) · BMC Physiology · doi:10.1186/1472-6793-1-7 · Cited by 58
Quinolinic acid reduces the antioxidant defenses in cerebral cortex of young rats
Leipnitz, G., Schumacher, C., Scussiato, K., Dalcin, K. B., Wannmacher, C. M. D., Wyse, Â. T. D. S., Dutra‐Filho, C. S., Wajner, M., & Latini, A. (2005) · International Journal of Developmental Neuroscience · doi:10.1016/j.ijdevneu.2005.08.004 · Cited by 58
Vassiliou, E. K., Kesler, O. M., Tadros, J. H., & Ganea, D. (2008) · The Journal of Immunology · doi:10.4049/jimmunol.181.7.4534 · Cited by 57
Tissue distribution of indoleamine 2,3-dioxygenase in normal and malaria-infected tissue
Hansen, A. M., Driussi, C., Turner, V. F., Takikawa, O., & Hunt, N. H. (2000) · Redox Report · doi:10.1179/135100000101535384 · Cited by 56
Photooxidation of Lens Proteins with Xanthurenic Acid: A Putative Chromophore for Cataractogenesis¶
Roberts, J. E., Finley, E. L., Patat, S. A., et al. (2001) · Photochemistry and Photobiology · doi:10.1562/0031-8655(2001)0740740polpwx2.0.co2 · Cited by 53
Eleftheriadis, T., Pissas, G., Antoniadi, G., Spanoulis, A., Liakopoulos, V., & Stefanidis, I. (2014) · International Immunology · doi:10.1093/intimm/dxu077 · Cited by 52
Ability of IDO To Attenuate Liver Injury in α-Galactosylceramide–Induced Hepatitis Model
Ito, H., Hoshi, M., Ohtaki, H., Taguchi, A., Ando, K., Ishikawa, T., Osawa, Y., Hara, A., Moriwaki, H., Saito, K., et al. (2010) · The Journal of Immunology · doi:10.4049/jimmunol.0904173 · Cited by 52
Miche, H., Brumas, V., & Berthon, G. (1997) · Journal of Inorganic Biochemistry · doi:10.1016/s0162-0134(97)00005-6 · Cited by 51
Gaubert, S., Bouchaut, M., Brumas, V., & Berthon, G. (2000) · Free Radical Research · doi:10.1080/10715760000300451 · Cited by 51
l -Tryptophan–Kynurenine Pathway Metabolites Regulate Type I IFNs of Acute Viral Myocarditis in Mice
Hoshi, M., Matsumoto, K., Ito, H., Ohtaki, H., Arioka, Y., Osawa, Y., Yamamoto, Y., Matsunami, H., Hara, A., Seishima, M., et al. (2012) · The Journal of Immunology · doi:10.4049/jimmunol.1100997 · Cited by 51
Early kynurenine pathway activation following cardiac arrest in rats, pigs, and humans
Ristagno, G., Fries, M., Brunelli, L., Fumagalli, F., Bagnati, R., Russo, I., Staszewsky, L. I., Masson, S., Volti, G. L., Zappalà, A., et al. (2013) · Resuscitation · doi:10.1016/j.resuscitation.2013.06.002 · Cited by 49
Molecular Basis for the Substrate Stereoselectivity in Tryptophan Dioxygenase
Capece, L., Lewis-Ballester, A., Marti, M. A., Estrin, D. A., & Yeh, S. (2011) · Biochemistry · doi:10.1021/bi201439m · Cited by 49
Effect of 3-hydroxyanthranilic acid on the mitochondrial respiratory system
Quagliariello, E., Papa, S., Saccone, C., & Alifano, A. (1964) · Biochemical Journal · doi:10.1042/bj0910137 · Cited by 49
Mailankot, M., & Nagaraj, R. H. (2010) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2010.04.014 · Cited by 48
Pazos, M., Andersen, M. L., & Skibsted, L. H. (2006) · Journal of Agricultural and Food Chemistry · doi:10.1021/jf062134n · Cited by 48
Kato, A., Suzuki, Y., Suda, T., Suzuki, M., Fujie, M., Takita, T., Furuhashi, M., Maruyama, Y., Chida, K., & Hishida, A. (2010) · Hemodialysis international. International Symposium on Home Hemodialysis · doi:10.1111/j.1542-4758.2010.00464.x · Cited by 47
Stążka, J., Luchowski, P., Wielosz, M., Kleinrok, Z., & Urbańska, E. M. (2002) · European Journal of Pharmacology · doi:10.1016/s0014-2999(02)01943-x · Cited by 46
Parada-Turska, J., Rzeski, W., Zgrajka, W., Majdan, M., Kandefer‐Szerszeń, M., & Turski, W. A. (2005) · Rheumatology International · doi:10.1007/s00296-005-0057-4 · Cited by 46
Immuno-localization of kynurenine aminotransferase (KAT) in the rat medulla and spinal cord
Kapoor, R., Okuno, E., Kido, R., et al. (1997) · Neuroreport · doi:10.1097/00001756-199711100-00039 · Cited by 46
Lee, H. J., Bach, J., Chae, H., Lee, S. H., Joo, W. S., Choi, S. H., Kim, K. Y., Lee, W. B., & Kim, S. S. (2004) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2004.02191.x · Cited by 46
Isolation and Expression of a cDNA Clone Encoding Human Kynureninase
Alberati-Giani, D., Buchli, R., Malherbe, P., Broger, C., Lang, G., Köhler, C., Lahm, H., & Cesura, A. M. (1996) · European Journal of Biochemistry · doi:10.1111/j.1432-1033.1996.0460u.x · Cited by 44
Anti-infectious Activity of Tryptophan Metabolites in the L-Tryptophan-L-Kynurenine Pathway
Narui, K., Noguchi, N., Saito, A., Kakimi, K., Motomura, N., Kubo, K., Takamoto, S., & Sasatsu, M. (2009) · Biological and Pharmaceutical Bulletin · doi:10.1248/bpb.32.41 · Cited by 44
Tryptophan Metabolites as Scavengers of Reactive Oxygen and Chlorine Species
Weiß, G., Diez‐Ruiz, A., Murr, C., Theur, I., & Fuchs, D. (2002) · Pteridines · doi:10.1515/pteridines.2002.13.4.140 · Cited by 44
Photochemical Studies on Xanthurenic Acid¶
Roberts, J. E., Wishart, J. F., Martínez, L. J., & Chignell, C. F. (2000) · Photochemistry and Photobiology · doi:10.1562/0031-8655(2000)0720467psoxa2.0.co2 · Cited by 43
Frolova, L. Y., Grigorieva, A. Y., Sudomoina, M. A., & Kisselev, L. L. (1993) · Gene · doi:10.1016/0378-1119(93)90568-n · Cited by 43
Antioxidant activity of tryptophan in rats under experimental endotoxic shock
Bitzer-Quintero, O. K., Dávalos-Marín, A. J., Ortíz, G. G., Angel‐Meza, A. R. D., Torres-Mendoza, B. M., Gaxiola‐Robles, R., Chaparro-Huerta, V., & Beas‐Zárate, C. (2009) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2009.07.002 · Cited by 42
Murakami, K., Haneda, M., & Yoshino, M. (2006) · BioMetals · doi:10.1007/s10534-005-4528-6 · Cited by 42
Lead Discovery for Human Kynurenine 3-Monooxygenase by High-Throughput RapidFire Mass Spectrometry
Lowe, D. M., Gee, M., Haslam, C. P., Leavens, B. J., Christodoulou, E., Hissey, P., Hardwicke, P. I., Argyrou, A., Webster, S. P., Mole, D. J., et al. (2013) · SLAS DISCOVERY · doi:10.1177/1087057113518069 · Cited by 42
Organ Distribution of Rat Kynureninase and Changes of Its Activity during Development
Kawai, J., Okuno, E., & Kido, R. (2017) · Enzyme · doi:10.1159/000469117 · Cited by 42
Zinellu, A., Sotgia, S., Mangoni, A. A., Sanna, M., Satta, A. E., & Carru, C. (2014) · Nutrition Metabolism and Cardiovascular Diseases · doi:10.1016/j.numecd.2014.11.004 · Cited by 39
Ren, S., Liu, H., Licad-Coles, E., & Correia, M. A. (1996) · Archives of Biochemistry and Biophysics · doi:10.1006/abbi.1996.0368 · Cited by 36
Lee, A., Kanuri, N. D., Zhang, Y., Sayuk, G. S., Li, E., & Ciorba, M. A. (2014) · PLoS ONE · doi:10.1371/journal.pone.0115848 · Cited by 35
Kynurenic acid protects against the homo-cysteine-induced impairment of endothelial cells
Wejksza, K., Rzeski, W., & Turski, W. A. (2009) · Pharmacological Reports · doi:10.1016/s1734-1140(09)70130-6 · Cited by 35
Moroni, F., Carpenedo, R., Cozzi, A., Meli, E., Chiarugi, A., & Pellegrini-Giampietro, D. E. (2003) · Advances in experimental medicine and biology · doi:10.1007/978-1-4615-0135-0_15 · Cited by 34
Walsh, H. A., & Botting, N. P. (2002) · European Journal of Biochemistry · doi:10.1046/j.1432-1033.2002.02854.x · Cited by 33
3-Hydroxykynurenine Oxidizes α-Crystallin: Potential Role in Cataractogenesis
Korlimbinis, A., Hains, P. G., Truscott, R. J. W., & Aquilina, J. A. (2006) · Biochemistry · doi:10.1021/bi051737+ · Cited by 33
Dong-Ruyl, L., Sawada, M., & Nakano, K. (1998) · Neuroscience Letters · doi:10.1016/s0304-3940(98)00120-7 · Cited by 33
Murakami, K., Ito, M., & Yoshino, M. (2001) · Journal of Nutritional Science and Vitaminology · doi:10.3177/jnsv.47.306 · Cited by 33
Reszka, K. J., Bilski, P. J., Chignell, C. F., & Dillon, J. P. (1996) · Free Radical Biology and Medicine · doi:10.1016/0891-5849(95)02018-7 · Cited by 32
Mailankot, M., Staniszewska, M., Butler, H., Caprara, M., Howell, S., Wang, B.-L., Doller, C. M., Reneker, L., & Nagaraj, R. (2009) · Laboratory Investigation · doi:10.1038/labinvest.2009.22 · Cited by 31
Lens epithelial cell apoptosis and intracellular Ca2+increase in the presence of xanthurenic acid
Malina, H. Z., Richter, C., Frueh, B. E., et al. (2002) · BMC Ophthalmology · doi:10.1186/1471-2415-2-1 · Cited by 29
Trabanelli, S., Očadlíková, D., Evangelisti, C., Parisi, S., & Curti, A. (2011) · Current Medicinal Chemistry · doi:10.2174/092986711795656054 · Cited by 29
Plangár, I., Zádori, D., Klivènyi, P., Toldi, J., & Vécsei, L. (2011) · Journal of Alzheimer s Disease · doi:10.3233/jad-2011-110131 · Cited by 27
Presence of kynurenic acid and kynurenine aminotransferases in the inner retina
Ręjdak, R., Żarnowski, T., Turski, W. A., et al. (2001) · Neuroreport · doi:10.1097/00001756-200112040-00014 · Cited by 27
Impairment of Kynurenine Metabolism in Cardiovascular Disease
Rudzite, V., Sileniece, G., Liepina, D., Dalmane, A., & Zirne, R. (1991) · Advances in experimental medicine and biology · doi:10.1007/978-1-4684-5952-4_89 · Cited by 23
Yu, P., Mosbrook, D. M., & Tagle, D. A. (1999) · Mammalian Genome · doi:10.1007/s003359901102 · Cited by 23
Pigott, E., DuHadaway, J. B., Muller, A. J., Gilmour, S. K., Prendergast, G. C., & Mandik‐Nayak, L. (2014) · Autoimmunity · doi:10.3109/08916934.2014.914507 · Cited by 22
Santiago‐López, D., Vázquez‐Román, B., de la Cruz, V. P., Barrera, D., Rembao, D., Salinas‐Lara, C., Pedraza‐Chaverrí, J., Galván‐Arzate, S., Ali, S. F., & Santamaría, A. (2004) · Synapse · doi:10.1002/syn.20084 · Cited by 17
Konradsson-Geuken, Å., Wu, H., Gash, C., Alexander, K. S., Campbell, A., Sozeri, Y., Pellicciari, R., Schwarcz, R., & Bruno, J. P. (2010) · Neuroscience · doi:10.1016/j.neuroscience.2010.05.052 · Cited by 15
Masoumy, M., Yu, J. C.-K., Liu, J. Y., Yanasak, N. E., Middleton, C., Lamoke, F., Mozaffari, M. S., & Baban, B. (2014) · PLoS ONE · doi:10.1371/journal.pone.0095720 · Cited by 9
Cited by
Aron-Wisnewsky, J., Warmbrunn, M. V., Nieuwdorp, M., & Clément, K. (2021) · Gastroenterology · doi:10.1053/j.gastro.2020.10.057 · Cited by 452
Inflammation, vitamin B6 and related pathways
Ueland, P. M., McCann, A., Midttun, Ø., & Ulvik, A. (2017) · Molecular Aspects of Medicine · doi:10.1016/j.mam.2016.08.001 · Cited by 382
Wang, R., Li, B., Lam, S. M., & Shui, G. (2020) · Journal of Genetics and Genomics · doi:10.1016/j.jgg.2019.11.009 · Cited by 330
The Role of Inflammation in CKD
Kadatane, S. P., Satariano, M., Massey, M., Mongan, K., & Raina, R. (2023) · Cells · doi:10.3390/cells12121581 · Cited by 322
Castro-Portuguez, R., & Sutphin, G. L. (2020) · Experimental Gerontology · doi:10.1016/j.exger.2020.110841 · Cited by 281
Metadata
- Authors
- Zou, M.-H.
- Venue
- Frontiers in Bioscience
- Publisher
- IMR Press
- Published
- 2015
- Volume
- 20
- Issue
- 7
- Pages
- 1116-1143
- ISSN
- 1093-4715 (ISSN-L)
- 1093-9946
- DOI
- 10.2741/4363
- OpenAlex
- W2471827535
- Cited by
- 361
- References
- 195
- FWCI
- 4.04
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.